Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

NCT03664843 · clinicaltrials.gov ↗
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

First Hospital of Shijiazhuang City

Collaborators